Publications
Engstrom PF, Arnoletti JP, Benson AB, Berlin JD, Berry JM, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Knol JA, Leong LA, Lin E, Mulcahy MF, Rohren E, Ryan DP, Saltz L, Shibata D, Skibber JM, Small W, Sofocleous C, Thomas J, Venook AP, Willett C, NCCN. NCCN clinical practice guidelines in oncology. Anal carcinoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2010. PMID: 20064293
Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. The oncologist. 2010. PMID: 21115576
Martin SA, Hewish M, Lord CJ, Ashworth A. Genomic instability and the selection of treatments for cancer. The Journal of pathology. 2010. PMID: 19890832
Lencioni R, Chen XP, Dagher L, Venook AP. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? The oncologist. 2010. PMID: 21115580
Chou J, Provot S, Werb Z. GATA3 in development and cancer differentiation: cells GATA have it! Journal of cellular physiology. 2010. PMID: 19798694
Kim TK, Billard MJ, Wieder ED, McIntyre BW, Komanduri KV. Co-engagement of alpha(4)beta(1) integrin (VLA-4) and CD4 or CD8 is necessary to induce maximal Erk1/2 phosphorylation and cytokine production in human T cells. Human immunology. 2010. PMID: 19815047
Rebecca L. Olin, Dan T. Vogl, Edward A. Stadtmauer. Allogeneic Transplantation for the Treatment of Multiple Myeloma. Allogeneic Stem Cell Transplantation. 2010. PMID:
Armstrong EJ, Bhave P, Wong D, Ursell PC, Kaplan L, Yeghiazarians Y, Ai WZ. Left ventricular rupture due to HIV-associated T-cell lymphoma. Texas Heart Institute journal. 2010. PMID: 20844622
Barok M, Balazs M, Lazar V, Rakosy Z, Toth E, Treszl A, Vereb G, Colbern GT, Park JW, Szollosi J. Characterization of a novel, trastuzumab resistant human breast cancer cell line. Frontiers in bioscience (Elite edition). 2010. PMID: 20036907
Logan AC, Goodnough LT. Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting. Hematology. American Society of Hematology. Education Program. 2010. PMID: 21239786
Shah S, Small E. Emerging biological observations in prostate cancer. Expert review of anticancer therapy. 2010. PMID: 20014889
Soon CW, Algazi AP, Cha EN, Daud AI. New horizons in melanoma treatment: targeting molecular pathways. The Ochsner journal. 2010. PMID: 21603363
Logan AC, Goodnough LT. Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting. Hematology. American Society of Hematology. Education Program. 2010. PMID: 21239786
Greenberg S, Rugo HS. Triple-negative breast cancer: role of antiangiogenic agents. Cancer journal (Sudbury, Mass.). 2010. PMID: 20164688
Soon CW, Algazi AP, Cha EN, Daud AI. New horizons in melanoma treatment: targeting molecular pathways. The Ochsner journal. 2010. PMID: 21603363
Ehrlich LI,* Oh DY,* Weissman IL, Lewis RS. *co-first author.. Differential contribution of chemotaxis and substrate restriction to segregation of immature and mature thymocytes Immunity.. 2009. PMID:
Shah NP. Fine-tuning targeted therapy of CML. Blood. 2009. PMID: 19965702
Damon LE, Damon LE. Mobilization of hematopoietic stem cells into the peripheral blood. Expert review of hematology. 2009. PMID: 21082960
Ashworth A. Familial breast cancer: the first linkage. The Lancet. Oncology. 2009. PMID: 19959078
Lin HJ, Neidich JA, Salazar D, Thomas-Johnson E, Ferreira BF, Kwong AM, Lin AM, Jonas AJ, Levine S, Lorey F, Rosenblatt DS. Asymptomatic maternal combined homocystinuria and methylmalonic aciduria (cblC) detected through low carnitine levels on newborn screening. The Journal of pediatrics. 2009. PMID: 19914430